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1. Introduction 
Since the discovery [ 1 ] that liver mitochondria 
isolated from glucagon-treated rats show an increased 
rate of pyruvate carboxylation, evidence for mito- 
chondrial action(s) of this hormone is growing. In 
addition to the effects on pyruvate metabolism [l-7] 
glucagon administration has been demonstrated to 
increase mitochondrial respiration [5,7-l 11, ATP 
formation [7,10,12], ATPase activity and K’ uptake 
[ 131, citrulline formation [6] , hydroxyl ion con- 
centration [7,9] and membrane potential [7]. With 
respect to the regulation of gluconeogenesis the 
observation is of special interest that glucagon 
markedly lowered the levels of 2-oxoglutarate and 
glutamate in the perfused liver [14,15] , and in the 
cytosolic and mitochondrial compartments of isolated 
liver cells [ 121. Therefore the present study examined 
whether glucagon treatment of the intact rat might 
lead to changes in the hepatic metabolism of 2-0x0- 
glutarate persisting after isolation of the mitochon- 
dria. 
2. Materials and methods 
2.1. Animals 
Normal fed male Sprague-Dawley rats (E. Jautz, 
Kisslegg) 200-300 g, were anaesthetized by intra- 
peritoneal injection of 0.1 ml/kg nembutal@ (Abbott, 
Ingelheim). They were allowed to sleep for 20-30 min 
prior to a tail vein injection of 20 Erg glucagon in 
0.1 ml solvent [8]. Controls received the solvent 
only. 
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2.2. Chemicals 
Glucagon was kindly donated by Hoechst, 
Frankfurt-Hoechst. Enzymes and coenzymes were 
purchased from Boehringer, Mamtheim. Sodium 
2-0~0 [ 1-14C] glutarate was obtained from New 
England Nuclear, Dreieichenhain. Sucrose p.a., 
phenazine methosulfate and phenethylamine were 
products of Roth, Karlsruhe. Ethyleneglycol bis 
@-aminoethylether)NJ’-tetraacetic acid and 
morpholinopropane sulfonic acid came from Serva, 
Heidelberg. (N-Tris (hydroxymethyl) methyl 2-amino- 
ethane sulfonic acid, rotenone and cysteinesulfinate 
were bought from Sigma, Munich. Lubrol WX was a 
gift of ICI, Frankfurt. Bovine serum albumin was 
supplied by Behringwerke, Marburg. The source of 
2,6dichlorophenolindophenol and all other reagents 
was Merck, Darmstadt. 
2.3. Methods 
Mitochondria from livers removed 20 min after 
glucagon injection were prepared as in [6] . Mito- 
chondria from heart muscle were prepared as in [ 161. 
Hepatic metabolite contents were determined in 
perchloric acid extracts of freeze-clamped liver samples 
prepared and analyzed by the methods in [ 12,171. 
Succinate dehydrogenase (EC 1.3.99.1) was 
assayed at 16°C spectrophotometrically as in [18] 
using about 150 ng protein/ml reaction mixture. The 
activity of glutamate dehydrogenase (EC 1.4.1.3) 
was measured at 25°C by the method in [ 191 after 
appropriate dilution of the mitochondrial suspension 
with 20 mM potassium phosphate buffer, pH 7.0 con- 
taining 1% Lubrol. The same buffer mixture fortified 
with 5% (v/v) normal rat serum was used for extrac- 
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tion of 2-oxoglutarate dehydrogenase (EC 1.2.4.2) 
just prior to the assay with the system in [20] except 
that pyruvate was replaced by 2-oxoglutarate. 
Oxygen consumption was measured polarographi- 
tally at 28°C using a Clark-type electrode under the 
conditions in [8] except that succinate was 2 mM 
and rotenone was omitted if not stated otherwise. 
The respiratory control ratios ranged from 4-10 and 
3-5 for liver and heart mitochondria, respectively. 
Mitochondria were stored at 30-40 mg protein/ml 
isolation medium, the protein being determined by 
the biuret method [21] employing KCN to correct 
for turbidity [22]. 
Tabulated data are given as the means f SEM for 
the numbers of different mitochondrial preparations 
in parentheses. Statistical significance P of the mean 
values was calculated according to Student’s t-test and 
is indicated in the tables for values below 0.05. 
3. Results and discussion 
In agreement with [8-lo] we found [ 1 l] that 
glucagon treatment of Wistar rats increases the ADP- 
stimulated respiration of the subsequently isolated 
liver mitochondria in the presence of a variety of sub- 
strates. In the present study using Sprague-Dawley 
rats state 3 respiration with succinate as the substrate 
was likewise enhanced, the stimulatory effect lasting 
at least for 60 min (table 1). In the presence of 
2-oxoglutarate state 3 respiration was increased from 
65.5 + 3.1 to 79.1 + 3.3 nmol O/min/mg protein 
(n = 29; P <0.0025) 20 min after glucagon injection, 
whereas no change in state 4 respiration was detect- 
able (data not shown). In contrast to liver, heart 
muscle mitochondria obtained from the same animals 
failed to display an increased rate of respiration after 
glucagon administration (table 2). 
In order to get information on the stability of the 
glucagon effect we measured the oxygen consumption 
of liver mitochondria kept on ice for various times. 
The results summarized in table 3 indicate that the 
property of increased state 3 respiration is retained 
upto 17h. 
So far no information is available concerning the 
question whether glucagon administered to the intact 
rat acts directly on liver mitochondria or by involve- 
ment of extrahepatic factor(s). Therefore, we have 
performed liver perfusion experiments which revealed 
that undiminished stimulation of state 3 respiration 
Table 1 
Increased respiration of liver mitochondria as a function of time after glucagon 
injection 
State 3 respiration 
(nmol O/min/mg protein) 
- 
Time 
Onin) 
Control Glucagon P 
20 137.4 * 5.4 178.2? 5.7 <0.0005 
(35) (35) 
60 135.7 f 4.3 180.7 * 11.4 <0.0025 
(6) (6) 
120 152.5 f 10.5 159.4 jl 10.2 
(5) (5) 
Rats were injected with glucagon as described in section 2 and livers were 
removed at the times indicated. Anaesthesia was maintained by injecting 50% 
first pentobarbital dose every 50 min. Oxygen consumption was measured at’ 
29°C in the presence of 2 mM succinate. State 4 respiration after 20 min was 
increased by glucagon from 31 .O f 1.7 to 35.5 f 1.8 nmol O/min/mg protein 
(n = 32; P < 0.05) 
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Table 2 
Effect of ghrcagon treatment of intact rats on ADP-stimulated respiration of mito- 
chondria isolated from liver and heart muscle 
State 3 respiration 
(nmol O/min/mg protein) 
Organ Control Glucagon P 
Liver 120.1 ?; 7.7 175.8 f 8.3 <0.0005 
Heart muscle 291.9 f 25.4 312.0 f 23.6 
The organs were removed 20 min after the injection of ghrcagon (see section 2). 
Respiration at 2 mM succinate was measured in the presence of 1 MM rotenone. 
Mean values f SEM of 8 control rats and 8 ghtcagon-treated rats are given 
Table 3 
Stability of the effect of ghtcagon treatment on the ADP-stimulated respiration 
of rat liver mitochondria 
State 3 respiration 
(nmol O/ming/mg protein) 
Tie 
01) 
Control Glucagon P 
0 117.1 f 7.1 158.2 f 6.3 <0.0005 
(8) (8) 
2 108.6 f 6.1 143.3 f 7.5 < 0.0025 
(8) (8) 
4 97.9 f 5.2 143.8 f 5.1 < 0.0005 
(8) (8) 
8 78.9 f 4.3 112.7 f 10.4 <0.005 
(8) (8) 
17 66.2 f 4.4 90.1 f 6.9 <O.Ol 
(8) (8) - 
22 47.2 f 7.1 60.6 * 3.2 
(6) (6) 
Mitochondria from the livers removed 20 min after glucagon injection were kept 
on ice for the times indicated prior to the measurement of oxygen consumption 
with succinate (2 mM) as the substrate 
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Table 4 
ADP-stimulated respiration of mitochondria isolated from livers perfused with 
glucagon or 3’:s’.cyclic AMP 
Addition to 
perfusate 
Solvent 
Final con- 
centration 
- 
State 3 respiration 
(rim01 O/min/mg protein) P 
98.7 f 6.5 
(7) 
Glucagon 2 &ml 131.5 f 4.6 <0.0025 
(7) 
S-AMP 0.2 mM 106.4 f 8.1 
(8) 
3’:5’-eAMP 0.2 mM 132.3 r 5.9 <0.0125 
(8) 
Rat livers were perfused at 34°C in a standard recirculating system with Gaze-free 
Krebs-Henseleit bicarbonate buffer rna~~~ed at pH 7.4 by gassing with 95% 
0,-S% CO,. The effecters were added as a single dose (0.2-1.0 ml) to the 
perfusate (100 ml) after 5 min equilibration to give the final concentrations indi- 
cated and perfusion was continued for 25 min. Respiratory substrate was 2 mM 
succinate 
by glucagon and also by 3’S’-cyclic AMP (table 4) 
occurs in vitro. 
As to the physiological meaning of the increase of 
the respiration rate, it is of interest hat it was 
accompanied by marked changes inhepatic metabolite 
contents as summarized in table 5. In addition to 
these results, which are qualitatively similar to [23 ] , 
we found that 60 min after glucagon injection the 
amount of glutamate was still decreased (PCO.0 125) 
while the levels of 2-oxoglutarate, malate and citrate 
were no longer si~i~cantly different from the con- 
trols. in order to see whether the increase in hepatic 
malate could be related to the mitochondrial action(s) 
of glucagon, the rate of malate production from 
2-oxoglutarate and succinate of mitochondria isolated 
from control and ~ucagon-treated rats was deter- 
mined. From the data of table 6 it appears conceiv- 
able that the increase of the malate levels and citrate 
occurring in the liver after glucagon (table 5) resulted 
from an enhanced flux of 2-oxoglutarate hrough the 
citric acid cycle. 
Table 5 
Effect of glucagon treatment of rats on hepatic metabolite contents 
Metabolite Amount (nmol/g fresh wt) 
Control Glucagon P 
Malate 3192 22 706 * 108 <0.0025 
Glutamate 2087 rt 132 1539 f 162 <0.0125 
2-Oxoglutarate 145 f 10 llO* 10 <O.Ol 
Citrate 362r 31 522* 54 <O.Ol 
Livers were freeze clamped 20 mm aftei ghrcagon application and extracted with 
HClO, as described in section 2. Means f SEM for 14 different rats in each group 
are given 
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Table 6 
Effect of glucagon treatment of rats on malate production from 2-oxoglutarate 
and succinate by isolated liver mitochondria 
Malate production 
(nmol/min/mg protein) 
Substrate lmM1 Control Glucagon P 
2-Oxoglutarate 18 1.74 -t 0.17 2.16 f 0.18 <o.os 
(14) (14) 
Succinate 9 6.44 f 0.29 7.62 f 0.48 <0.025 
(13) (13) 
The rate of malate production at 25’C was determined in a reaction mixture con- 
taining 0.2 ml medium [ 81 for respiration measurements, 0.05 ml 0.2 M glucose, 
0.01 ml 0.6 M 2oxoglutarate or 0.3 M succinate, 0.01 ml 0.1 M ADP and 0.01 ml 
hexokinase, corresponding to 14 U. Incubation began with addition of 0.05 ml 
mitochondria, corresponding to about 2 mg protein and was terminated with 
0.05 ml 70% (w/v) of HClO,. Malate production was linear with time up to 10 min 
To assess the possible site(s) of glucagon action we 
measured the activities of 2-oxoglutarate dehydro- 
genase, glutamate dehydrogenase and succinate dehy- 
drogenase in crude mitochondrial extracts. No effect 
of hormone treatment was discernible with regard to 
the activities of glutamate dehydrogenase and 2-0x0- 
glutarate dehydrogenase which amounted to 
4961 * 274 (n = 18) and 35.7 f 2.2 (n = 29) mU/mg 
protein, respectively. The respective values of the 
controls were 4828 + 298 (n = 18) and 35.8 f. 1.7 
(n = 3 1) mU/mg protein. In the case of succinate 
dehydrogenase, however, the enzyme activity was 
found to be significantly (Z’ <O.OOOS) increased in 
liver mitochondria from animals that had received 
glucagon. At 16’C the rate of succinate oxidation 
shown by control mitochondria was 8 1.3 + 6.9 
(n = 27) nmol/min/mg protein, a value 50% lower 
than that of mitochondria from glucagon-injected 
rats, which was determined to be 126.5 + 9.6 (n = 27) 
nmol/min/mg protein. This stimulatory effect was 
neither abolished by freezing and thawing of the 
mitochondrial suspension nor by treatment with 0.2% 
Lubrol. Thus the hormone effect was attributable 
rather to a persistent change in the catalytical func- 
tion of succinate dehydrogenase than to an improved 
permeability of the inner membrane for the assay 
components. In view of the fact that the specific 
activity of succinate dehydrogenase was about 4-fold 
Table 7 
Effect of glucagon treatment of intact rats on the activity of 
2-oxoglutarate dehydrogenase activity in intact mitochondria 
and mitochondrial extracts at 25“C 
Preparation 2Oxoglutarate decarboxylation 
(nmol/min/mg protein) 
Intact mitochondria 
Lysed mitochondria 
a P <0.0005 
Control 
12.4 * 0.9 
29.7 f 3.3 
Glucagon 
20.3 + O.ga 
25.6 f 2.7 
Mean values + SEM for 10 different preparations in each 
group are given. Further details are described in section 2. 
The rate of 2-0x0-[ l-‘4C]glutarate decarboxylation by intact 
mitochondria was determined as follows: to a prewarmed 
plastic vial containing 0.2 ml medium [ 81 for respiration 
measurements and 0.01 ml 0.1 M ADP, at 25”C, 0.02 ml 
mitochondrial suspension, corresponding to about 250 pg 
protein, was added and mixed prior to the addition of 0.02 ml 
80 mM 2-0x0-[ l-‘4C]glutarate corresponding to 0.2 r&i. 
Immediately thereafter the vials were closed with a rubber 
cap equipped with a center well containing 0.1 ml phenethyl- 
amine. Incubation at 25°C was terminated at 2 mm intervals 
by injection of 0.2 ml 2 N H,SO,. The velocity of “CO, for- 
mation in the first 2-4 mm was somewhat lower than the 
linear rate between 4 - 10 min 
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that of extractable 2-oxoglutarate dehydrogenase it 
appears difficult to appraise the physiological relevance 
of the st~ulation of succinate dehydrogenase follow- 
ing glucagon ad~nistration. Nevertheless, we could 
show that malate formation from succinate (like that 
from 2-oxoglutarate) was stimulated by glucagon 
treatment (table 6). The rate-limiting role of 2-0x0- 
glutarate dehydrogenase b came ven more apparent, 
when the rate of 2-oxoglutarate decarboxylation by 
mitochondrial extracts was compared with that 
realized in the intact organelle. The data of table 7 
indicate that under control conditions the flux 
through 2-oxoglutarate dehydrogenase corresponds 
to only 40% total extractable nzyme activity. This 
restraint was found to be remarkably relieved (table 7) 
in the mitochondria from glucagon-treated animals. 
(Identical results were obtained with mitochondria 
preincubated for substrate depletion for 5 min with 
ADP prior to the addition of 2-oxo-[l-‘4C]glutarate, 
thereby ruling out the possibility of isotope dilution 
by endogenous substrate.) Compared with the nor- 
mal and hormone-stimulated rates of state 3 oxygen 
consumption of 65.6 + 2.6 and 76.0 + 2.5 nmol 
O/min/mg protein (n = IO; P <O.OOS), respectively, 
one might conclude from the flux measurements 
performed with these ~tochondria (table 7) that 
glucagon arbitration caused 2-oxoglutarate o
become the preferred substrate of mitochondrial 
respiration. 
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